The Sohn Conference Foundation pursues preeminent and bold initiatives that will have the greatest impact to treat and cure pediatric cancer.
All proceeds from the 2020 Sohn Investment Conference in New York will be dedicated to Rockefeller University scientists working on some of the highest-risk, highest-reward projects primed to advance the treatment of pediatric brain cancer. Founded in 1901 to improve the understanding of life for the benefit of humanity, Rockefeller is one of the world’s leading biomedical research institutions. Rockefeller scientists have garnered 25 Nobel Prizes in Chemistry or Medicine, a number that would rank the institution as fourth in the world if it was its own country. We’re excited to come together to support Rockefeller’s culture of excellence, which is unrivaled among research institutions worldwide.
In addition to New York, Sohn conferences around the globe bring together the investment community in a powerful and impactful way to benefit charity.